Eric G. Carter - 14 Aug 2023 Form 4 Insider Report for AEON Biopharma, Inc. (AEON)

Role
Director
Signature
/s/ Alexander Wilson, Attorney-in-Fact
Issuer symbol
AEON
Transactions as of
14 Aug 2023
Transactions value $
$0
Form type
4
Filing time
16 Aug 2023, 17:05:23 UTC
Previous filing
24 Jul 2023
Next filing
21 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AEON Stock Option Award $0 +58,851 $0 58,851 14 Aug 2023 Common Stock 58,851 $5.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of stock options on August 14, 2023, which vests in three yearly installments from August 14, 2023, subject to the reporting person's continued service through the applicable vesting date.